Search / Trial NCT00000281

Pharmacotherapy for Schizophrenic Drug Users - 6

Launched by YALE UNIVERSITY · Sep 20, 1999

Trial Information

Current as of December 07, 2024

Completed

Keywords

Anti Psychotic Agents

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Please contact site for information.

Trial Officials

Thomas R Kosten, M.D.

Principal Investigator

VA Connecticut Healthcare System

About Yale University

Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.

Locations

New Haven, Connecticut, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials